Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05965778
Status:
RECRUITING
Last Update Posted:
2024-04-29
First Post:
2023-07-20
Brief Title:
Comparison of the Performance and Safety of T2769 Versus Vismed Multi in the Treatment of Moderate to Severe Dry Eye Syndrome
Sponsor:
Laboratoires Thea
Organization:
Laboratoires Thea
Study Overview
Official Title:
Comparison of the Performance and Safety of T2769 Versus Vismed Multi in the Treatment of Moderate to Severe Dry Eye Syndrome
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate the non-inferiority of T2769 compared to Vismed Multi in terms of total ocular surface staining Oxford score after 35 days of treatment
To evaluate the performance and safety of T2769 versus Vismed Multi
To evaluate the performance and safety of T2769 versus Vismed Multi
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None